BECTON DICKINSON MEDICAL (S) PTE LTD

Becton Dickinson Medical (S) Pte Ltd specializes in single-use hypodermic needles. These devices are designed for medical injections, including subcutaneous and intramuscular administration, such as those in the BD Hypoint™ series. The focus is on ensuring safe and precise delivery of medications or fluids in clinical settings.

Becton Dickinson Medical (S) Pte Ltd is based in the United States. While the company’s headquarters location does not directly determine regulatory approval, it operates under the oversight of U.S. regulatory bodies like the FDA. This means its devices, such as the BD Hypoint™ series, must comply with U.S. regulatory requirements, including classification and listing in databases like the FDA’s Unique Device Identifier (UDI) system.

The devices produced by Becton Dickinson Medical (S) Pte Ltd, such as the BD Hypoint™ series, are listed in the FDA’s Unique Device Identifier (UDI) database. This registry helps track and identify medical devices authorized for use in the U.S., ensuring transparency and traceability in the healthcare system.

The hypodermic needles produced by Becton Dickinson Medical (S) Pte Ltd, including those in the BD Hypoint™ series, are classified as Class II devices. This classification is determined by regulatory authorities based on factors like the device’s risk level and intended use. Class II devices typically require special controls in addition to general controls to ensure their safety and effectiveness, such as performance standards or post-market surveillance.